Literature DB >> 31954682

Overexpression of Mfsd2a attenuates blood brain barrier dysfunction via Cav-1/Keap-1/Nrf-2/HO-1 pathway in a rat model of surgical brain injury.

Pinar Eser Ocak1, Umut Ocak2, Prativa Sherchan3, Marcin Gamdzyk3, Jiping Tang3, John H Zhang4.   

Abstract

INTRODUCTION: Disruption of the blood brain barrier (BBB) and subsequent cerebral edema formation is one of the major adverse effects of brain surgery, leading to postoperative neurological dysfunction. Recently, Mfsd2a has been shown to have a crucial role for the maintenance of BBB functions. In this study, we aimed to evaluate the role of Mfsd2a on BBB disruption following surgical brain injury (SBI) in rats.
MATERIALS AND METHODS: Rats were subjected to SBI by partial resection of the right frontal lobe. To evaluate the effect of Mfsd2a on BBB permeability and neurobehavior outcome following SBI, Mfsd2a was either overexpressed or downregulated in the brain by administering Mfsd2a CRISPR activation or knockout plasmids, respectively. The potential mechanism of Mfsd2a-mediated BBB protection through the cav-1/Nrf-2/HO-1 signaling pathway was evaluated.
RESULTS: Mfsd2a levels were significantly decreased while cav-1, Nrf-2 and HO-1 levels were increased in the right frontal perisurgical area following SBI. When overexpressed, Mfsd2a attenuated brain edema and abolished neurologic impairment caused by SBI while downregulation of Mfsd2a expression further deteriorated BBB functions and worsened neurologic performance following SBI. The beneficial effect of Mfsd2a overexpression on BBB functions was associated with diminished expression of cav-1, increased Keap-1/Nrf-2 dissociation and further augmented levels of Nrf-2 and HO-1 in the right frontal perisurgical area, leading to enhanced levels of tight junction proteins following SBI. The BBB protective effect of Mfsd2a was blocked by selective inhibitors of Nrf-2 and HO-1.
CONCLUSIONS: Mfsd2a attenuates BBB disruption through cav-1/Nrf-2/HO-1 signaling pathway in rats subjected to experimental SBI.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood brain barrier; Brain edema; Cav-1; Caveolae; Mfsd2a; Surgical brain injury

Mesh:

Substances:

Year:  2020        PMID: 31954682      PMCID: PMC7038791          DOI: 10.1016/j.expneurol.2020.113203

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  65 in total

1.  Epigallocatechin-gallate stimulates NF-E2-related factor and heme oxygenase-1 via caveolin-1 displacement.

Authors:  Yuanyuan Zheng; Andrew Morris; Manjula Sunkara; Joseph Layne; Michal Toborek; Bernhard Hennig
Journal:  J Nutr Biochem       Date:  2011-03-29       Impact factor: 6.048

2.  Mitoquinone attenuates blood-brain barrier disruption through Nrf2/PHB2/OPA1 pathway after subarachnoid hemorrhage in rats.

Authors:  Tongyu Zhang; Shancai Xu; Pei Wu; Keren Zhou; Lingyun Wu; Zhiyi Xie; Weilin Xu; Xu Luo; Peng Li; Umut Ocak; Pinar Eser Ocak; Zachary D Travis; Jiping Tang; Huaizhang Shi; John H Zhang
Journal:  Exp Neurol       Date:  2019-02-16       Impact factor: 5.330

3.  Reduced HO-1 protein expression is associated with more severe neurodegeneration after transient ischemia induced by cortical compression in diabetic Goto-Kakizaki rats.

Authors:  Tiago J T P Moreira; Aleta Cebere; Gvido Cebers; Claes-Göran Ostenson; Suad Efendic; Sture Liljequist
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-04       Impact factor: 6.200

4.  Modification of kynurenine pathway via inhibition of kynurenine hydroxylase attenuates surgical brain injury complications in a male rat model.

Authors:  George Zakhary; Prativa Sherchan; Qian Li; Jiping Tang; John H Zhang
Journal:  J Neurosci Res       Date:  2019-06-30       Impact factor: 4.164

Review 5.  Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Authors:  Robert D Bell; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2009-03-25       Impact factor: 17.088

6.  Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011.

Authors:  John D Rolston; Seunggu J Han; Catherine Y Lau; Mitchel S Berger; Andrew T Parsa
Journal:  J Neurosurg       Date:  2013-11-22       Impact factor: 5.115

7.  Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.

Authors:  Sukriti Nag; Roopa Venugopalan; Duncan J Stewart
Journal:  Acta Neuropathol       Date:  2007-08-09       Impact factor: 17.088

8.  PCB 126 toxicity is modulated by cross-talk between caveolae and Nrf2 signaling.

Authors:  Michael C Petriello; Sung Gu Han; Bradley J Newsome; Bernhard Hennig
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-04       Impact factor: 4.219

9.  Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats.

Authors:  R P Stroemer; T A Kent; C E Hulsebosch
Journal:  Stroke       Date:  1995-11       Impact factor: 7.914

10.  Mfsd2a (Major Facilitator Superfamily Domain Containing 2a) Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Disruption by Inhibiting Vesicular Transcytosis.

Authors:  Yuan-Rui Yang; Xiao-Yi Xiong; Juan Liu; Li-Rong Wu; Qi Zhong; Kai Zhou; Zhao-You Meng; Liang Liu; Fa-Xiang Wang; Qiu-Wen Gong; Mao-Fan Liao; Chun-Mei Duan; Jie Li; Mei-Hua Yang; Qin Zhang; Chang-Xiong Gong; Qing-Wu Yang
Journal:  J Am Heart Assoc       Date:  2017-07-19       Impact factor: 5.501

View more
  7 in total

1.  Targeting Mfsd2a in hemorrhagic cerebrovascular diseases.

Authors:  Pinar Eser; Mevlut Ozgur Taskapilioglu; Hasan Kocaeli
Journal:  Transl Stroke Res       Date:  2022-03-29       Impact factor: 6.829

2.  Inhibition of mast cell tryptase attenuates neuroinflammation via PAR-2/p38/NFκB pathway following asphyxial cardiac arrest in rats.

Authors:  Umut Ocak; Pinar Eser Ocak; Lei Huang; Weilin Xu; Yuchun Zuo; Peng Li; Marcin Gamdzyk; Gang Zuo; Jun Mo; Guangyu Zhang; John H Zhang
Journal:  J Neuroinflammation       Date:  2020-05-04       Impact factor: 8.322

3.  Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrier.

Authors:  Maxwell Eisenbaum; Andrew Pearson; Arissa Gratkowski; Benoit Mouzon; Michael Mullan; Fiona Crawford; Joseph Ojo; Corbin Bachmeier
Journal:  Fluids Barriers CNS       Date:  2021-10-26

4.  Selective sphingosine-1-phosphate receptor 1 modulator attenuates blood-brain barrier disruption following traumatic brain injury by inhibiting vesicular transcytosis.

Authors:  Yuan Zhang; Lin Wang; Qiuling Pan; Xiaomin Yang; Yunchuan Cao; Jin Yan; Yingwen Wang; Yihao Tao; Runjin Fan; Xiaochuan Sun; Lin Li
Journal:  Fluids Barriers CNS       Date:  2022-07-11

5.  Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats.

Authors:  Min Zhou; Dongna Li; Qian Shen; Lei Gao; Pengwei Zhuang; Yanjun Zhang; Hong Guo
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

Review 6.  Mechanisms of Blood-Brain Barrier Dysfunction in Traumatic Brain Injury.

Authors:  Alison Cash; Michelle H Theus
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

7.  Burns Impair Blood-Brain Barrier and Mesenchymal Stem Cells Can Reverse the Process in Mice.

Authors:  Jie Yang; Kui Ma; Cuiping Zhang; Yufan Liu; Feng Liang; Wenzhi Hu; Xiaowei Bian; Siming Yang; Xiaobing Fu
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.